ANA reports that the South African Federation of Trade Unions (Saftu) has welcomed the Competition Commission’s investigation into price fixing allegations against pharmaceutical companies.  

The investigation follows concerns raised by Advocates for Breast Cancer, the Cancer Alliance, the Cancer Association of SA and public interest organisation Section 27.  “The pharmaceutical companies that are currently being investigated include Roche, which supplies lifesaving breast cancer medicine in South Africa, Pfizer, which supplies lung cancer medicine, and Aspen which provides lifesaving medicine for different forms of cancer,” Saftu said in a statement.  The new federation went on to state that it was in agreement with the Competition Commission “that the healthcare sector, and in particular, pharmaceuticals, is a priority sector for its enforcement efforts due to the likely negative impact that anti-competitive conduct in that sector would have on consumers in general and specifically the poor and vulnerable.”

• Read this report in full at IOL News
• See too, Saftu welcomes price-fixing probe into pharmaceutical companies, at EWN

Get other news reports at the SA Labour News home page